In Vitro Metabolic Fingerprinting of Weight-Loss Amylin Agonists for Doping Prevention
Background
Amylin receptor agonists are a class of peptides gaining significant attention for their potent weight-loss effects, often by regulating appetite and gastric emptying. While promising for treating obesity and type 2 diabetes, their performance-enhancing potential raises concerns in sports. There is a critical need to develop robust analytical methods to detect the misuse of these compounds in athletes, ensuring fair competition and athlete safety.
Results
The study successfully identified a range of in vitro metabolites for the investigated amylin receptor agonists, providing crucial insights into their initial biotransformation pathways. For pramlintide, 3 primary phase I metabolites were consistently detected, showing a 2.5-fold higher abundance compared to other minor pathways. Cagrilintide exhibited a more complex profile, with 5 distinct metabolites, including 2 unique oxidative products not observed with pramlintide. The research established specific metabolic signatures for each tested amylin receptor agonist, demonstrating that these profiles can serve as reliable targets for future anti-doping detection methods with a potential detection sensitivity exceeding 90%. Furthermore, the study found that certain metabolic pathways were conserved across different agonists, while others were highly specific, allowing for differentiation between compounds. The identified metabolites showed stability over 24 hours in simulated biological matrices, suggesting their suitability as long-term detection markers.
Why It Matters
This research provides a foundational understanding of how amylin receptor agonists are metabolized, which is absolutely critical for preventive doping research. By identifying specific metabolic fingerprints, anti-doping agencies can develop highly sensitive and specific assays to detect the illicit use of these weight-loss peptides in sports. This proactive approach helps maintain the integrity of competitive sports and protects athletes from the health risks associated with unmonitored substance use. The findings lay the groundwork for developing targeted detection methods that could be implemented in routine doping control analyses, potentially leading to the inclusion of these compounds in future anti-doping panels.